- Home
- RLAY vs AOSL Comparison
RLAY vs AOSL Comparison
Compare RLAY & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AOSL
- Stock Information
- Founded
- RLAY 2015
- AOSL 2000
- Country
- RLAY United States
- AOSL United States
- Employees
- RLAY N/A
- AOSL N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AOSL Semiconductors
- Sector
- RLAY Health Care
- AOSL Technology
- Exchange
- RLAY Nasdaq
- AOSL Nasdaq
- Market Cap
- RLAY 1.1B
- AOSL 986.5M
- IPO Year
- RLAY 2020
- AOSL 2010
- Fundamental
- Price
- RLAY $5.11
- AOSL $28.09
- Analyst Decision
- RLAY Strong Buy
- AOSL Buy
- Analyst Count
- RLAY 9
- AOSL 3
- Target Price
- RLAY $20.88
- AOSL $38.00
- AVG Volume (30 Days)
- RLAY 1.3M
- AOSL 356.0K
- Earning Date
- RLAY 11-06-2024
- AOSL 11-04-2024
- Dividend Yield
- RLAY N/A
- AOSL N/A
- EPS Growth
- RLAY N/A
- AOSL N/A
- EPS
- RLAY N/A
- AOSL N/A
- Revenue
- RLAY $10,006,000.00
- AOSL $658,528,000.00
- Revenue This Year
- RLAY N/A
- AOSL $6.06
- Revenue Next Year
- RLAY N/A
- AOSL $8.22
- P/E Ratio
- RLAY N/A
- AOSL N/A
- Revenue Growth
- RLAY N/A
- AOSL N/A
- 52 Week Low
- RLAY $5.03
- AOSL $19.38
- 52 Week High
- RLAY $12.14
- AOSL $47.45
- Technical
- Relative Strength Index (RSI)
- RLAY 28.59
- AOSL 38.62
- Support Level
- RLAY $5.96
- AOSL $25.97
- Resistance Level
- RLAY $6.39
- AOSL $28.60
- Average True Range (ATR)
- RLAY 0.36
- AOSL 2.25
- MACD
- RLAY -0.04
- AOSL -0.28
- Stochastic Oscillator
- RLAY 5.10
- AOSL 19.12
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AOSL Alpha and Omega Semiconductor Limited
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.